외상성 뇌손상 평가 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Traumatic Brain Injuries Assessment Market was valued at USD 2.3 billion in 2025 and is estimated to grow at a CAGR of 5.2% to reach USD 4 billion by 2035.

Market expansion is driven by the increasing prevalence of head injuries, the rising number of sports-related and military-associated TBIs, and ongoing advancements in neuroimaging and diagnostic technologies. Traumatic brain injury assessment involves a comprehensive clinical, cognitive, and neurological evaluation to determine the severity, functional impact, and overall outcome of brain injuries. It incorporates neurological tests, behavioral assessments, imaging techniques, and biomarker analysis to facilitate prompt diagnosis, treatment planning, and prognosis. The market is further fueled by innovations in CT, MRI, EEG, and biomarker-based diagnostics, enabling faster and more accurate detection of mild and moderate TBIs, which were often overlooked previously. Growing adoption of AI-driven analytics, objective diagnostic tools, and blood-based screening solutions is also reshaping the industry.

The screening devices segment held an 80.1% share in 2025, due to their rapid, cost-effective, and non-invasive assessment capabilities. These devices are essential for early detection and prioritization of suspected brain injuries in emergency and point-of-care settings, driving their widespread adoption.

The hospitals segment held a 57.9% share in 2025, expected to reach USD 2.4 billion during 2026-2035. Hospitals remain the primary care centers for head injury patients, with high patient inflow demanding advanced assessment tools. Rising road traffic incidents and age-related injuries are key factors contributing to increased hospital admissions, reinforcing the need for efficient TBI evaluation solutions.

U.S. Traumatic Brain Injuries Assessment Market was valued at USD 881.6 million in 2025. North America's demand is largely fueled by head injuries stemming from accidents, falls, and other causes, creating significant pressure on emergency care providers to adopt rapid and accurate diagnostic tools. The reliance on advanced neurodiagnostic solutions in hospitals and emergency units continues to drive the U.S. market forward.

Key players in the Global Traumatic Brain Injury Assessment Market include Philips, BrainScope, INTEGRA, RAUMEDIC, Fujifilm, Natus Medical, GE Healthcare, BIOMERIEUX, Oculogica, NIHON KOHDEN, InfraScan, SIEMENS Healthineers, COMPUMEDICS, and ZOLL Medical. To strengthen their presence, companies are pursuing strategies such as launching advanced diagnostic tools with faster turnaround times, integrating AI and machine learning into imaging platforms, and developing non-invasive biomarker-based tests. Many firms are expanding geographically to access high-growth regions and forming partnerships with hospitals, research institutions, and emergency care providers. Investment in marketing campaigns, training programs for healthcare professionals, and after-sales support ensures broader adoption and improved clinical outcomes.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing incidence of traumatic brain injuries
    • 3.2.1.2 Technological advancements in traumatic brain injuries assessment
    • 3.2.1.3 Increasing demand for non-invasive devices for TBI assessment
    • 3.2.1.4 Rising awareness regarding traumatic brain injury
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Dearth of skilled professionals
    • 3.2.2.2 High cost of assessment devices
  • 3.2.3 Market opportunities
    • 3.2.3.1 Development of portable and point-of-care assessment tools
    • 3.2.3.2 Emerging markets with untapped demand
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Consumer insights
• 3.7 Pricing analysis, 2024
• 3.8 Future market trends
• 3.9 Value chain analysis
• 3.10 Porter's analysis
• 3.11 PESTEL analysis
• 3.12 Gap analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Competitive positioning matrix
• 4.5 Competitive analysis of major market players
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Screening devices
  • 5.2.1 Computerized tomography (CT) scan
  • 5.2.2 Magnetic resonance imaging (MRI)
  • 5.2.3 Other screening devices
• 5.3 Monitoring devices
  • 5.3.1 Intracranial pressure (ICP) monitoring
  • 5.3.2 Partial pressure of oxygen in brain tissue (pBrO2)

Chapter 6 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Diagnostic centers
• 6.4 Other end use

Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 BIOMERIEUX
• 8.2 BrainScope
• 8.3 COMPUMEDICS
• 8.4 FUJIFILM
• 8.5 GE Healthcare
• 8.6 InfraScan
• 8.7 INTEGRA
• 8.8 Natus Medical
• 8.9 NIHON KOHDEN
• 8.10 Oculogica
• 8.11 PHILIPS
• 8.12 RAUMEDIC
• 8.13 SIEMENS Healthineers
• 8.14 ZOLL Medical